May 9 |
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
Apr 24 |
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Apr 15 |
Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?
|
Apr 11 |
Black Diamond Therapeutics Announces Changes to Board of Directors
|
Apr 8 |
Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know
|
Apr 7 |
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
|